Clinical Profile and Management Outcomes of Ocular Sarcoidosis - A One-Year Study
Background: Ocular sarcoidosis is a systemic inflammatory disease that can result in severe visual impairment if not diagnosed and treated early. This study aimed to evaluate the clinical presentation, diagnostic indicators, treatment modalities, and outcomes in patients with ocular sarcoidosis. Materials and Methods: A total of 40 patients (50 eyes) diagnosed with ocular sarcoidosis were enrolled in this prospective study conducted at Narayana Medical College, Nellore, between January 2009 and December 2009. Patient demographics, clinical features, ocular signs, laboratory investigations, and treatment outcomes were assessed over a follow-up period of 6 months. Data were analyzed using descriptive statistics. Results: The mean age of the patients was 34.9 years, with a predominance of female patients (62.5%). Defective vision was the most common symptom (95%), followed by pain (60%). Ocular signs included granulomatous keratic precipitates (92.5%) and anterior chamber reaction (90%). Systemic investigations revealed bilateral hilar lymphadenopathy in 50% of the patients. The majority of patients were treated with topical steroids (100%), and 90% received oral steroids. At the 6-month follow-up, 37.5% showed improvement in visual acuity, while 12.5% experienced deterioration. Conclusion: Ocular sarcoidosis presents predominantly with defective vision and inflammatory signs such as granulomatous keratic precipitates and anterior chamber reaction. Early diagnosis and treatment, primarily with steroids, are critical for improving visual outcomes. However, long-term management remains essential due to potential recurrence and complications.